The global anti-tuberculosis therapeutics market, valued at USD 1354.00 million in 2024, is projected to reach USD 2816.71 million by 2034, growing at a CAGR of 7.60%. This growth is driven by rising TB incidence and increasing research in tuberculosis therapeutics, offering valuable insights for pharmaceutical stakeholders and healthcare providers. https://www.expertmarketresearch.com/reports/anti-tuberculosis-therapeutics-market